Menu

CME Corner

Active Programs

Diagnosing and Classifying Heart Failure in Primary Care

Heart failure is common in the United States, affecting about 6.5 million adults. Although nearly 1 million new cases are diagnosed annually, delays in diagnosis are frequent. Patients who are at risk for heart failure do not often receive appropriate recommended testing. And when diagnosed, heart failure is often misclassified or not classified, which can lead to mismanagement. This activity will ...

  • Mobile + Online on Univadis Mobile + Online on Univadis
  • ACCME

Managing Heart Failure in the Primary Care Setting

Heart failure is common in the United States, affecting about 6.5 million adults. This activity will examine considerations for the management of patients with heart failure in the primary care setting. ...

  • Mobile + Online on Univadis Mobile + Online on Univadis
  • ACCME

Strategies for Achieving LDL-C Goals to Reduce ASCVD Risk

There are numerous treatment options available for the management of familial hypercholesterolemia (FH) and non-familial hypercholesterolemia, but many patients remain unable to achieve optimal reductions in their LDL-C levels. This interactive case-based activity will examine the consequences of elevated LDL-C and explore strategies for achieving target LDL-C goals. ...

  • Online Presentation Online Presentation
  • ACCME

Secondary Prevention of ASCVD: Novel Therapies to Improve Outcomes in Patients with Hypercholesterolemia (AANP Program ID 17012508)

This activity will examine the current discussions surrounding statin use and the potential application of PCSK9 inhibitors. *Learners will be redirected to the AANP website. ...

  • Online Presentation
  • AANP

Expired Programs

Improving Outcomes in Patients with Heart Failure: Closing the Gaps

In the United States, heart failure (HF) affects about 5.7 million adults, accounts for >1 million hospitalizations annually, and is the leading cause of hospitalization for adults >65 years of age. Despite diagnostic and therapeutic advances in the last several decades and improved survival rates, roughly 50% of people with HF die within 5 years of diagnosis. Rates of cardiovascular death or HF-r ...

  • Online Presentation
  • ACCME
Main Menu
EDITOR'S PICKS